210 related articles for article (PubMed ID: 30986244)
1. Passenger mutations accurately classify human tumors.
Salvadores M; Mas-Ponte D; Supek F
PLoS Comput Biol; 2019 Apr; 15(4):e1006953. PubMed ID: 30986244
[TBL] [Abstract][Full Text] [Related]
2. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
3. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
4. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
6. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
7. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
8. Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples.
Ji S; Zhu T; Sethia A; Wang W
Genome Res; 2024 May; 34(4):633-641. PubMed ID: 38589250
[TBL] [Abstract][Full Text] [Related]
9. Identification of cancer driver genes based on nucleotide context.
Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
[TBL] [Abstract][Full Text] [Related]
10. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
11. A machine learning approach for somatic mutation discovery.
Wood DE; White JR; Georgiadis A; Van Emburgh B; Parpart-Li S; Mitchell J; Anagnostou V; Niknafs N; Karchin R; Papp E; McCord C; LoVerso P; Riley D; Diaz LA; Jones S; Sausen M; Velculescu VE; Angiuoli SV
Sci Transl Med; 2018 Sep; 10(457):. PubMed ID: 30185652
[TBL] [Abstract][Full Text] [Related]
12. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract][Full Text] [Related]
13. Predicting the functional consequences of somatic missense mutations found in tumors.
Carter H; Karchin R
Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
15. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
16. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
17. Ontology-based prediction of cancer driver genes.
Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the evaluation of cancer driver genes.
Tokheim CJ; Papadopoulos N; Kinzler KW; Vogelstein B; Karchin R
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14330-14335. PubMed ID: 27911828
[TBL] [Abstract][Full Text] [Related]
20. Confidence-based somatic mutation evaluation and prioritization.
Löwer M; Renard BY; de Graaf J; Wagner M; Paret C; Kneip C; Türeci O; Diken M; Britten C; Kreiter S; Koslowski M; Castle JC; Sahin U
PLoS Comput Biol; 2012; 8(9):e1002714. PubMed ID: 23028300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]